SPECIFIC RESEARCH INTERESTS 

• Clinical decision support
• Health information exchange
• Telehealth
• Population health
• Registries/”Big Data”
• Informatics education of medical students, residents, and fellows

Selected Recent Projects

Risk Adjustment: MetroHealth has implemented two Hierarchical Condition Category (HCC) models for risk adjustment: CMS (Medicare) and HHS (Marketplace).  We will be implementing a third model – CDPS (Chronic Illness and Disability Payment System) – for the Medicaid population.  These are models are used to estimate expected resource utilization for a population of patients, which can play a role in reimbursement under non-fee-for-service payment models.

Population Health Management: MetroHealth uses bulk orders for Mammography and Fecal Immunochemical Testing, and soon will be starting a pilot with Cologuard.  In addition to writing and maintaining the reports which identify patients for whom orders are appropriate, I also have created reports and associated batch processes to find and cancel obsolete bulk orders (defined as orders which are no longer necessary, either because a separate order was resulted, or because the patient no longer needs or wants screening).

Compliance with DEA Telemedicine Prescribing Regulations: The COVID-19 Public Health Emergency officially ended on 5/11/2023, and with that, certain regulatory flexibilities have ended or will end soon.  One is the ability to prescribe controlled substances during telemedicine encounters for patients whom the prescriber has not previously seen in-person.  Beginning 11/1/2023, these telemedicine prescribing flexibilities will come to an end, which will disallow certain prescribing of controlled substances outside of an in-person visit.  Drs. Bar-Shain and Greco have worked closely with MetroHealth Compliance and Legal experts to ensure that prescribers will know whether or not they can legally prescribe controlled substances within a given telemedicine encounter.